Late-stage RSV vaccine trials show 'exciting promise,' some scientists say
This highly-magnified, 1981 transmission electron microscopic image, reveals some of the morphologic traits exhibited by a human respiratory syncytial virus.
As featured on
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) …